This may not be of great importance clinically as therapy decisions for chemotherapy in TNBC patients (as in HER2-positve patients) are usually made without considering further tumor-related characteristics because therapy efficacy is high and there is a lack of alternative treatment options. Here, ERBB2 is linked to neoplasm.